Zevra Therapeutics Announces Final CHMP Opinion on Arimoclomol for the Treatment of Niemann-Pick Disease Type C (NPC) in the European Union
European Commission to make final decision on arimoclomol MAA following negative CHMP opinion BOSTON, Nov. 13, 2026 (GLOBE…
#Europe #EU #(NPC) #Announces #arimoclomol #C #CHMP #disease #European #EuropeanUnion #final #for #in #Niemann-Pick #of #on #Opinion #the #therapeutics #treatment #Type #Union #Zevra
https://www.europesays.com/europe/180983/